Anteotech Ltd
Research Anteotech Ltd (ADO) on Bullrun: market cap AUD 58.68M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerADO
- ExchangeAU
- CountryAustralia
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyAUD
- Market capAUD 58.68M
- Financial periodFY2025
- RevenueAUD 968.88K
- Revenue growth110.4%
- Net income-AUD 6.76M
- Free cash flow-AUD 6.05M
- Gross margin100.0%
Valuation Snapshot
latest market cap is AUD 58.68M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 968.88K | -AUD 6.76M | -AUD 6.05M | 100.0% | 0 | AUD 2.34M | AUD 1.96M | AUD 3.15M |
| FY2024 | AUD 460.40K | -AUD 8.88M | -AUD 7.58M | 100.0% | 0 | AUD 5.03M | AUD 2.33M | AUD 5.31M |
| FY2023 | AUD 365.72K | -AUD 12.65M | -AUD 8.77M | 100.0% | -0.01 | AUD 2.72M | AUD 1.31M | AUD 2.38M |
| FY2022 | AUD 760.88K | -AUD 10.72M | -AUD 11.77M | 100.0% | -0.01 | AUD 10.10M | AUD 1.03M | AUD 12.36M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 58.68M | n/a | n/a | n/a |
About Anteotech Ltd
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company's products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests;
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Anteotech Ltd's market cap?
Anteotech Ltd's market capitalization is AUD 58.68M.
What does Anteotech Ltd do?
AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America.